Page 120 - IJPS-3-1
P. 120

Gender differences in hypertension-free life expectancy in Bangladesh

                                       to live 0.32 years (117 days) longer than men. The differences in LE decrease with
                                       increasing ages.


            Table 2.  LE, HFLE, and proportion of expected life without hypertension by age and sex in Bangladesh in 2011

                   Male                               Female                                Differences  Differences
                                                                                                           §
                                                                                             in LE
                                                                                                 †
                                                                                                     in HFLE
             Age              HFLF        Proportion of           HFLF
                  LE    HFLE              life without   LE  HFLE             Proportion of life  Male-  Male-
                              95% CI      HTN                     95% CI      without HTN   Female  Female
             35   38.92  30.69  (30.16, 31.23)  78.87  40.08  25.59  (24.94, 26.24)  63.86  -1.16   5.10*
             40   34.29  26.48  (25.95, 27.00)  77.21  35.45  21.71  (21.07, 22.36)  61.25  -1.16   4.76*
             45   29.77  22.56  (22.04, 23.08)  75.79  30.90  18.23  (17.60, 18.87)  59.01  -1.13   4.33*
             50   25.44  18.85  (18.34, 19.36)  74.09  26.44  15.10  (14.48, 15.72)  57.10  -1.00   3.75*
             55   21.35  15.57  (15.07, 16.08)  72.94  22.14  12.16  (11.57, 12.75)  54.92  -0.79   3.41*
             60   17.61  12.49  (12.00, 12.97)  70.90  18.18    9.60   (9.03, 10.18)  52.82  -0.57  2.88
             65   14.27   9.95   (9.48, 10.43)  69.76  14.59    7.07   (6.51, 7.64)  48.49  -0.32   2.88*
             70   11.28   7.92   (7.46, 8.38)  70.25  11.40    5.69   (5.16, 6.23)  49.94   -0.12   2.23*
            Notes:  LE: Life expectancy; HFLE: Hypertension-free life expectancy; HTN, Hypertension; CI: Confidence interval.
            †  Differences are not statistically tested.
            §  Differences are statistically tested.
            *  p < 0.01.


                                         Despite having longer LE, at each age, women could expect shorter HFLE than men
                                       in terms of both number and proportion of years. At age 35, women could expect 64%
                                       of their remaining life without HTN (LE: 40.08 years, HFLE: 25.59 years), while men
                                       could expect 79% of their remaining life without HTN (LE: 38.92 years, HFLE: 30.69
                                       years). At age 65, women and men, respectively, could expect 49% and 70% of their
                                       remaining life without HTN. Men at age 65 could expect a much greater proportion of
                                       their remaining life without HTN than women at age 35.
                                         Although women at age 35 could expect to live 1.16 years longer than men, they
                                       could expect 5.10 years shorter HFLE than could men. At age 65, women could expect
                                       117 days longer LE but 2.88 years shorter HFLE than men. The differences in HFLE
                                       also decrease with increasing ages.
                                         Table 3 displays the decomposition of LE with HTN into LE with four types of
                                       HTN by age and sex in Bangladesh in 2011. Across ages, and in terms of both number
                                       and proportion of years, men and women who were unaware of HTN could expect
                                       the longest LE with HTN, followed by men and women with uncontrolled HTN,
                                       controlled HTN, and those with awareness of HTN but who were not in treatment. At
                                       age 35, a woman and a man, respectively, could expect 6.44 and 4.46 years of life with
                                       unawareness of HTN, 3.79 and 1.74 years of life with uncontrolled HTN, 2.62 and 1.40
                                       years of life with controlled HTN, and 1.64 and 0.62 years of life with awareness of
                                       HTN but not receiving treatment. At age 65, a woman and a man, respectively, could
                                       expect 3.28 and 2.28 years of life with unawareness of HTN, 2.14 and 0.98 years of
                                       life with uncontrolled HTN, 1.11 and 0.81 years of life with controlled HTN, and
                                       0.99 and 0.25 years of life with awareness of HTN but not receiving treatment. The
                                       proportion of LE with HTN increases as age increases for both men and women, but
                                       the proportion of LE with HTN for men at age 65 is lower than the proportion of LE
                                       with HTN for women at age 35.
                                         Figure 1 displays HFLE and LE with four types of HTN by age and sex. Here,
                                       each bar represents LE, which comprises HFLE and LE with four types of HTN. At
                                       each age, for both men and women, HFLE accounts for the largest proportion of LE,
                                       followed by LE with unawareness of hypertension, LE with uncontrolled hypertension,
                                       LE with controlled hypertension, and LE with awareness of hypertension but no

            114                                 International Journal of Population Studies   2017, Volume 3, Issue 1
   115   116   117   118   119   120   121   122   123   124   125